Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinoma
2020 · Journal of Experimental & Clinical Cancer Research · 30 citations
https://doi.org/10.1186/s13046-020-1527-y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
627
Citations
12
h-index
14
i10-index
Peter A. Raven is an academic researcher. The author has contributed to research in topics: Cell Adhesion Molecules Research & Renal cell carcinoma treatment & Animal Genetics and Reproduction. The author has an h-index of 12, co-authored 37 publications.
ORCID: 0000-0003-0413-6944Click to start Chat